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Background: Carriage of either single or multiple pneumococcal serotypes (multiple carriage) is a prerequisite for
developing invasive pneumococcal disease. However, despite the reported high rates of pneumococcal carriage in
Malawi, no data on carriage of multiple serotypes has been reported previously. Our study provides the first description
of the prevalence of multiple pneumococcal carriage in Malawi.
Methods: The study was conducted in Blantyre and Karonga districts in Malawi, from 2008 to 2012. We recruited 116
children aged 0–13 years. These children were either HIV-infected (N = 44) or uninfected (N = 72). Nasopharyngeal
samples were collected using sterile swabs. Pneumococcal serotypes in the samples were identified by microarray.
Strains that could not be typed by microarray were sequenced to characterise possible genetic alterations within the
capsular polysaccharide (CPS) locus.
Results: The microarray identified 179 pneumococcal strains (from 116 subjects), encompassing 43 distinct serotypes
and non-typeable (NT) strains. Forty per cent (46/116) of children carried multiple serotypes. Carriage of vaccine type
(VT) strains was higher (p = 0.028) in younger (0–2 years) children (71 %, 40/56) compared to older (3–13 years) children
(50 %, 30/60). Genetic variations within the CPS locus of known serotypes were observed in 19 % (34/179) of the strains
identified. The variants included 13-valent pneumococcal conjugate vaccine (PCV13) serotypes 6B and 19A, and the
polysaccharide vaccine serotype 20. Serotype 6B variants were the most frequently isolated (47 %, 16/34). Unlike the
wild type, the CPS locus of the 6B variants contained an insertion of the licD-family phosphotransferase gene. The CPS
locus of 19A- and 20-variants contained an inversion in the sugar-biosynthesis (rmlD) gene and a 717 bp deletion within
the transferase (whaF) gene, respectively.
Conclusions: The high multiple carriage in Malawian children provides opportunities for genetic exchange through
horizontal gene transfer. This may potentially lead to CPS locus variants and vaccine escape. Variants reported here
occurred naturally, however, PCV13 introduction could exacerbate the CPS genetic variations. Further studies are
therefore recommended to assess the invasive potential of these variants and establish whether PCV13 would offer
cross-protection. We have shown that younger children (0–2 years) are a reservoir of VT serotypes, which makes them
an ideal target for vaccination.
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Gender Male 68 % (N = 46) 32 % (N = 22) 68
Female 54 % (N = 26) 46 % (N = 22) 48
IQR(Age) 1.4 (0.8-3.1) 4.9 (2.7-8.1)
A summary of subjects by HIV status, gender and age (in years). The children
were aged between 0 and 13 years. The interquartile range (IQR) for the
median age is included
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Every year, approximately 800 000 deaths that occur in
under-five children globally are attributed to invasive
pneumococcal disease (IPD) [1]. The majority of these
deaths are reported in Africa, with sub-Saharan Africa
(SSA) bearing the greatest burden [1]. Carriage of S.
pneumoniae is a pre-requisite of IPD, and for carriage to
occur, the pneumococcus has to establish itself on the
mucosal surfaces of the human nasopharynx [2].
Carriage plays a key role in pneumococcal transmis-
sion within the community [3]. An individual can carry
one or more pneumococcal serotypes at any given time
[4]. Carriage of two or more serotypes is defined as mul-
tiple carriage. With the increased availability of highly
sensitive serotyping techniques such as the microarray,
the full extent of global prevalence of multiple carriage
is emerging [4]. Microarray determines pneumococcal
serotype by detecting genes contained within the capsu-
lar polysaccharide (CPS) locus, which encode the poly-
saccharide capsule [5]. Microarray serotyping can be
used to detect (i) multiple carriage; (ii) carriage of other
bacterial species; (iii) the absence or presence of particular
genes, e.g. antibiotic resistance genes; (iv) non-typeable se-
rotypes (NTs); as well as (v) novel serotypes by detecting
genetic variations at the CPS locus itself [6].
Multiple carriage is reported to promote genetic re-
combination, characterised by the acquisition of genetic
elements from other microbes through transformation,
transduction or conjugative transfer [7]. Given the
pneumococcus is highly transformable and undergoes
genetic recombination through horizontal gene transfer
[8], recombination at the CPS locus may result in a
change in serotype (capsule switching) [9] which could
lead to vaccine escape [10]. Therefore, predicting the
emergence of vaccine escape in a high IPD burden
population such as in Malawi is crucial to understand-
ing the likely long-term public health effect of pneumo-
coccal vaccination.
In November 2011, Malawi introduced PCV13 in the
national infant immunisation programme. Conjugate vac-
cines clearly reduce the burden of vaccine serotype disease
and carriage [11]. However, the increase of non-vaccine
serotypes (NVT) in carriage post-vaccination, has led to
serotype replacement, which is a major concern [12]. In
settings with a high diversity of pneumococcal carriage,
serotype replacement may be exacerbated. Yet despite its
importance in pneumococcal evolution, evidence of mul-
tiple carriage in Africa has not been well documented.
In the study reported in this article, we investigated
the prevalence of multiple carriage and the degree of
naturally occurring genetic variation at the CPS loci for
important vaccine serotypes in Malawian children from
2008 to 2012, prior to country wide pneumococcal vac-
cine usage.Methods
Study setting
The study was conducted at the Malawi-Liverpool-
Wellcome Trust (MLW) Clinical Research Programme
(Blantyre, Malawi). Children were recruited from house-
holds in the northern (Karonga) region, and from outpa-
tients presenting at the Queen Elizabeth Central Hospital
(QECH) in the southern (Blantyre) region of Malawi.
QECH is a government-funded teaching hospital with 1
250 beds and provides clinical care to the population of
about 1 million people [13]. Laboratory analyses were per-
formed at MLW; St George’s Medical School, University
of London (London, UK) and the Wellcome Trust Sanger
Institute (WTSI, Cambridge, UK).
Study participants
The study population comprised children ranging from
0 to 13 years. These children were recruited between
2008 and 2012 as part of a routine surveillance study in-
vestigating pneumococcal carriage and transmission in
Malawi (Table 1). Consent to include the children in the
study was obtained from parents or guardians. The sam-
ples collected were stored at −80 °C in the MLW arch-
ive, which has over 5000 nasopharyngeal samples. The
samples analysed in this study were only from children
who were carriers of S. pneumoniae, following initial
screening based on colony morphology and optochin
(Oxoid, UK) sensitivity. We randomly screened 189 sam-
ples, out of which 116 were positive for S. pneumoniae,
representing a 61 % pneumococcal carriage rate. These
children included both males (N = 68) and females (N =
48) who were either HIV negative (N = 72) or HIV posi-
tive (N = 44). HIV positive children were identified from
the paediatric staging and ART outpatient clinics while
the HIV negative controls were recruited from those
children undergoing elective surgery for non-immune
related conditions. Trained nurses were responsible for
recruiting children into the study and collection of naso-
pharyngeal samples. The median age was significantly
higher for HIV positive children (4.9 years) than for HIV
negative children (1.4 years) (p = 0.001). However, there
was no significant age difference between male and fe-
male children (p = 0.5).
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Nasopharyngeal samples were collected from children
using sterile Dacron-tipped nasopharyngeal swabs (Med-
ical Wire and Equipment, Corsham, UK). The swabs
were immediately preserved in skim milk, tryptone,
glucose and glycerine (STGG) medium and then stored
at −80 °C until further analysis.
Culturing of S. pneumoniae
The frozen samples in STGG were briefly thawed to 4 °C.
An aliquot (~10 μl) of the STGG sample was then cul-
tured on sheep blood agar and gentamycin (SBG) selective
media (MLW, Malawi). A presumptive identification of
alpha-haemolytic streptococci as S. pneumoniae was made
by colony morphology and optochin (Oxoid, UK) sensitiv-
ity by disc diffusion. Samples containing S. pneumoniae
were then selected for further characterisation by a more
sensitive molecular serotyping by microarray.
DNA extraction
DNA extraction for microarray serotyping was performed
as described previously [14]. Briefly, for each sample, the
STGG containing tubes were briefly vortexed. Aliquots of
the STGG solution from the swabs were diluted 1:10 and
1:100 using Brain Heart Infusion (BHI) Broth (Oxoid,
UK). Each STGG dilution (50 μl) was plated onto a
colistin-oxolinic acid-blood agar [15] plate (Oxoid, UK)
and incubated overnight at 37 °C in 5 % CO2. DNA was
extracted from whole-plate sweeps using QIAamp DNA
Mini Kit (Qiagen, Germany). The DNA required for fur-
ther analysis by whole-genome sequencing was extracted
from single and morphologically distinct pneumococcal
colonies on a culture plate, following the DNA extraction
protocol above.
Serotyping of S. pneumoniae by microarray
Molecular serotyping was performed using the protocol
developed by the bacterial microarray group at St George’s
(BμG@S) medical school: The BμG@S SP-CPS v1.4.0
microarray (bugs.sgul.ac.uk). Standard Agilent protocols
for DNA labelling and hybridisation were used (Agilent,
UK). The processed microarray slides were scanned using
a high-resolution microarray scanner (Agilent, UK). Raw
intensity data were extracted using Agilent Feature Extrac-
tion software (Agilent, UK). The output was analysed using
an empirical Bayesian model to determine the pneumococ-
cal serotypes present and their relative abundance [6]. In
this study, pneumococcal serotypes were classified as ei-
ther: PCV13 vaccine types (VT), non-vaccine types (NVT)
or non-typeable (NT) strains [16].
Sequencing whole genomes of S. pneumoniae
Whole-genome sequencing was performed on the Illu-
mina HiSeq platform (CA, USA). The sequences wereiteratively assembled using Velvet algorithm [17]. To de-
termine genetic variations at the CPS loci, the reads
were mapped against reference sequences for each sero-
type in order to obtain fine mapping using Burrows-
Wheeler Aligner [18, 19]. The references used were for
serotypes 6B [GenBank: CR931639], 19A [GenBank:
CR931675] and 20 [GenBank: CR931679]. Single nucleo-
tide polymorphisms (SNPS) were called using SAMtools,
VCFtools and BCFtools [20]. In order to generate a mul-
tiple sequence alignment, we reduced the mapped binary
alignment map (BAM) files to a consensus sequence for
the CPS locus of each isolate used in the analysis. The
sequence reads for the wild type and CPS locus variant
pneumococcal isolates used for this analysis were depos-
ited in the European Nucleotide Archive (ENA) of the
European Bioinformatics Institute (EBI), accession num-
bers: [ERS003549, ERS006757, ERS006775, ERS012090,
ERS012138, ERS012143, ERS050261, ERS050288, ERS050336,
ERS050451, ERS096165, ERS096166, ERS096169, ERS096172,
ERS096173].Phylogenetic analysis
A phylogenetic tree of the CPS locus variants was gener-
ated using only the polymorphic sites identified from the
generated multiple sequence alignment, using RAxML
version 7.8.6 with a Gamma model accounting for the
rate heterogeneity among the sites [21]. To assess the re-
liability of the phylogeny, we performed 100 bootstrap
replicates. Comparative analysis of the CPS sequences
was performed using Artemis [22]. Previously charac-
terised Malawian invasive serotype 6B isolates [10] were
included in the phylogeny for comparison.Genetic recombination
Genetic recombination events were detected using the
Geneologies Unbiased By Recombination in Nucleotide
Substitutions (GUBBINS) tool [23]. Gubbins statistically
determines genomic loci with atypically high number of
variable sites, which is usually imported from exogenous
sources. All the variable sites that were present in the in-
ferred recombination regions were iteratively excluded
from the sequence alignment. This generated a robust
phylogeny whose evolution signals were not confounded
by recombination.Statistical analysis
Microarray serotyping data were analysed using Stata 11
(StataCorp, College Station, TX, USA). Graphs were gen-
erated using R statistical software (www.R-project.org)
and GraphPad Prism version 6.00 for Mac OS X (San
Diego California USA, www.graphpad.com).
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Results
Malawian children carry a broad range of pneumococcal
serotypes
The microarray identified 43 distinct serotypes in addition
to NTs amongst the 179-pneumococcal strains isolated
from the 116 children in this study (Fig. 1). VT serotypes
represented 60 % of all the serotypes detected. The NVT
serotypes accounted for 39 % of all the serotypes detected
and these were classified into either high-invasive (30 %)
or low-invasive (9 %) potential based on the reported glo-
bal frequency of isolation from invasive disease [24]. The
NT strains accounted for the remaining 1 % of the strains.
We further investigated the impact of age on carriage of
VT or NVT serotypes. Statistically, carriage of VT sero-
types was significantly higher in the younger (0–2 years)
than older children (71 %, 40/56 vs 50 %, 30/60; p =
0.028). However carriage of NVT serotypes was signifi-
cantly higher in the older compared to younger children
(50 %, 30/60 vs 29 %, 16/56; p = 0.028), suggesting that age
had an impact on carriage of VT and NVT serotypes
(Fig. 2). Serotype 1, which is the most isolated pneumo-
coccal strain from invasive disease in Malawi [25], was
only detected in 3 out of 116 children sampled, with two19
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Fig. 1 Serotype-specific pneumococcal carriage in Malawian children, dete
detected from 116 nasopharyngeal swabs, comprising 43 distinct pneumoc
graphs represent serotypes detected in HIV positive and HIV negative child
Non-Vaccine Type. The non-vaccine serotypes were subdivided into high (Non
on the global frequency of isolation from invasive disease [24]. Individuals carry
represents cumulative frequency of serotypes isolated and was used to estimacarriers in the 0–2 years age group and one carrier in
older children.
High prevalence of multiple carriage in Malawian children
We identified multiple carriage amongst 40 % (46/116)
of the children’s samples analysed, with 27 % (31/116) of
samples tested containing two serotypes, 11 % (13/116)
containing three serotypes, and 2 % (2/116) containing
four serotypes (Fig. 3). In those multiple carriage events,
61 % (28/46) co-carried at least one VT and an NVT,
15 % (7/46) carried VT only and 24 % (11/46) carried
NVT only. The NVT pneumococcal strains were most
abundant in 53.6 % (15/28) of multiple carriage events
that occurred with VT strains. Since conventional sero-
typing methods are biased towards detection of the most
abundant serotype, the VTs present at low abundance in
multiple carriage events may not have been detected in
these samples, which could have resulted in poor estima-
tion of the vaccine coverage. The effect of HIV infection
on multiple carriage was also investigated. Statistically,
there was no significant difference in the prevalence of
multiple carriage between HIV negative and HIV posi-
tive children (42 % vs 34 %, p = 0.34). The association
between age and multiple carriage was also investigated.
The children were divided into two groups: younger
children aged 0–2 years (N = 56) and older children aged
3–13 years (N = 60). There was no statistically significant
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Fig. 2 Age distribution for carriage of S. pneumoniae PCV13 (VT) and
non-PCV13 (NVT) serotypes. A total of 116 pneumococcal isolates were
analysed and categorised into three categories, namely carriage of only
PCV13 (VT) serotypes (N = 42), carriage of only non-PCV13 (NVT)
serotypes (N = 46) and carriage of both PCV13 and non-PCV13 (VT
and NVT) serotypes (N = 28). The data for the VT or NVT carriers
involved both single and multiple serotype carriage while the VT
and NVT subjects were all carriers of multiple serotypes
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Overall, there was also no statistically significant vari-
ation in the median age for single or multiple carriers of
pneumococcal serotypes (2.6 (1.5-5.0) vs 1.96 (1.1-3.9),
p = 0.28), suggesting that age did not have an impact on
multiple carriage.Fig. 3 Multiple carriage of S. pneumoniae serotypes in Malawian children. M
serotypes in the nasopharynx of Malawian children. The overall frequency o
samples expressing two (27 %, 31/116)), three (11 %, 13/116) or four (2 %,Evolution of the CPS genes belonging to pneumococcal
vaccine serotypes
Highly divergent genes within the CPS loci associated
with particular serotypes (6B, 19A and 20) were de-
tected. Serotypes 6B and 19A are included in PCV13
and serotype 20 is included in the pneumococcal poly-
saccharide vaccine PPV23. These 3 variants accounted
for over half of all the variants detected (34 % (16/37),
11 % (4/37) and 8 % (3/37) respectively). Given their
abundance, these variants were sequenced and charac-
terised to determine the genetic changes that had oc-
curred at the CPS locus.
How do the 6B CPS locus variants differ?
A phylogenetic analysis of Malawian 6B carriage variants
and Malawian 6B invasive serotypes showed two genetic-
ally distinct clusters (Fig. 4a & b). Genetic diversity was
determined through a single nucleotide polymorphisms
(SNPs) analysis between the variant and wild type. Results
showed that the CPS locus SNPs density was 50.7 SNPs/
Kbp/strain for 6B variants, higher than the 9.0 SNPs/Kbp/
strain in invasive 6B strains (Fig. 4a), showing a higher mu-
tation rate in variants compared to the wild type strains.
Variants demonstrate high genetic recombination
A recombination analysis showed four regions of re-
combination in all the 6B variants. These occurred in
wzg, wciO, rmlA and rmlC genes (Fig. 4b), whichicroarray was used to determine carriage of multiple pneumococcal
f multiple serotype carriage was 40 % (46/116), with co-colonising
2/116) capsular types
Fig. 4 Genetic composition of the CPS sequences in wild type and variant 6B serotypes. The CPS locus sequence of serotype 6B [CR931639] was
used as reference. The branches were coloured based on the type of the strain, either carriage (red), invasive (green), or reference (blue). a shows
the distribution of SNPs within the CPS locus among the variants and invasive 6B serotypes. The black marks to the right of the terminal taxa
represent location of SNPs within the CPS sequences. b shows the location of genetic recombination events. Unique recombination events are
coloured in blue and shared (non-unique) events are coloured in red. Branches matched with an asterisk (*) represent nodes with a bootstrap
value of 100 %
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putative ribitol transferase, glucose-1-phosphate thy-
midylyltransferase, and dTDP-4-keto-6-deoxy-D-glu-
cose 3,5-epimerase respectively. All the invasive 6B
serotypes showed recombination in the rmlA gene. All
the recombination events in the 6B variants were an-
cestral meaning they occurred a long time ago and
have since become fixed in the current circulating
population. This fixation may be due to a selective ad-
vantage it confers to the variant related to survival or
replication.CR931639 [6B]
dexB
Fig. 5 A comparison of the CPS locus sequence between serotype 6B varia
as having atypical CPS genes and were further analysed by whole-genome se
variants of serotype 6B and reference sequence CR931639 was performed usi
The 6B variant [ERS096169] harboured an intact allele of the licD-phosphotranA deletion within the licD-family phosphotransferase gene
Detailed analysis of the CPS loci showed that 6B variants
contained an intact allele of the licD-family phospho-
transferase gene, whereas the reference contained a
300 bp gene deletion (Fig. 5). The licD-family phospho-
transferase is involved in lipopolysaccharide biosynthesis
[26]. The CPS loci of the 6B variants were phylogenetic-
ally related to subtype III lineage (6B-III) isolated from
invasive disease in the Netherlands [27]. However, the
variants belonged to genotypes that were distinct from
6B-III based on multilocus sequence typing (Table 2),ERS096169
glf
nt and wild type. These variants were initially detected by microarray
quencing. A comparative analysis of the CPS locus sequences between
ng Artemis. The divergent gene(s) for the variant are highlighted in red.
sferase gene, while a 297 bp deletion was observed in the reference
Table 2 Multilocus sequence typing [46] of Malawian CPS locus variants
MLST house keeping genes
Strain ID Serotype Country sampled Sequence Type (ST) aroE gdh gki recP spi xpt ddl Closest Matching ST*
JF911504.1 6B-III Netherlands Novel 7 6 1 8 6 1 14
JF911507.1 6B-III Netherlands 90 5 6 1 2 6 3 4
ERS096173 6B Malawi Novel 2 8 1 10 17 1 19 2863 (33D) (DLV)
4441 (6C) (DLV)
5266 (22A) (DLV)
ERS096172 6B Malawi Novel 1 43 29 1 77 1 14 8783 (NT) (DLV)
ERS096166 6B Malawi Novel 10 9 4 5 15 20 28 6382 (6A) (SLV)
7744 (6A) (SLV)
ERS096165 6B Malawi Novel 10 9 4 5 15 4 2 6382 (6A) (DLV)
7744 (6A) (DLV)
ERS096169 6B Malawi Novel 54 5 4 5 36 142 269 8050 (6A) (SLV)
ERS096157 19A Malawi 2062 1 5 53 32 14 20 199
ERS096159 20 Malawi Novel 13 5 4 5 6 28 168 5392 (20) (DLV)
7651 (20) (DLV)
ERS096158 20 Malawi 5435 2 5 36 12 6 20 269
JF911504.1 and JF911507.1 are 6B-III subtypes previously described in Europe [27]. Serotypes with sample accession numbers ERS096165 –ERS096173 represent
carriage CPS locus variants of serotype 6B in Malawian children. All the Malawian 6B variants belonged to 6B-III subtypes based on phylogeny (data not shown).
Also shown are Multilocus sequence typing [46] profiles of serotypes 19A and 20 CPS locus variants. *Reference information obtained from MLST database
(speumoniae.mlst.net). SLV and DLV represent single locus variant or double locus variant respectively. ST represents sequence type
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and their phenotype is currently not known.
Analysis of serotype 19A and serotype 20 CPS locus
variants
The 19A variant showed an inversion in the rmlD gene
(Fig. 6). The rmlD gene, together with three other genes
(rmlA, rmlB, rmlC) encode for proteins involved in the
synthesis of rhamnose sugar [28], a component of the
wild type 19A polysaccharide capsule [5]. The inversion
may alter the expression of the rmlD gene, which may
affect the synthesis or change the molecular structure of
the polysaccharide capsule. The pattern of SNPs withinCR931675 [19A]
de
xB
Fig. 6 A comparison of the CPS locus sequence between serotype 19A var
as having unusual CPS genes and were further analysed by whole-genome se
serotype 19A and reference sequences CR931675. The divergent gene(s) for t
[ERS096157] showed an inversion in rmlD genethe 19A CPS locus variant and rmlD gene inversion was
identical to serotype 19A-I subtype [27]; however, the se-
quence types were different (Table 2) suggesting circula-
tion of a different clone in Malawi. The CPS locus
variant of serotype 20 displayed a 716 bp deletion within
the whaF gene (Fig. 7). This gene is located between the
wciD and wzx genes and encodes for putative glycosyl
transferase (GT) protein, involved in linking sugar mole-
cules to generate a repeat unit [5].
Discussion
This study characterised the diversity of pneumococcal






iant and wild type. These variants were initially detected by microarray
quencing. The CPS locus sequences were compared between variants of






Fig. 7 A comparison of the CPS locus sequence between serotype 20 variant and wild type. These variants were initially detected by microarray
as having unusual CPS genes and were further analysed by whole-genome sequencing. A comparative analysis of the CPS locus sequences between
variants of serotype 20 and reference sequences CR931679 was performed using EasyFig [47]. The divergent gene(s) for the variant are highlighted in
red. The serotype 20 variant [ERS096158] contained a 717 base pair gene deletion within the whaF gene compared to the reference (CR931679)
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higher diversity of pneumococcal serotypes in Malawian
children than reported elsewhere in Africa [29], where
serotyping was by a less sensitive latex agglutination
assay. The higher serotype diversity in Malawian chil-
dren could be attributed high rates of multiple carriage
and by the use of a more sensitive method of identifica-
tion. We also observed that carriage of NVT repre-
sented a high proportion (~40 %) of all serotypes
circulating in Malawi. These NVTs may ultimately in-
crease in the Malawian population due to serotype re-
placement following the recent introduction of PCV13
[11], potentially leading to an increase in NVT IPD
cases [12, 30]. A recent study in Germany has reported
an increase of IPD due to NVT serotypes 15A and 23B
post PCV13 [31]. Serotype 15A was detected in our
dataset (Fig. 1) and it would be important to monitor
the prevalence of serotype 15A and other NVT sero-
types in both carriage and IPD in Malawi, post PCV13.
We have shown, statistically, that younger children (0–
2 years) carried a significantly higher proportion of
PCV13 serotypes compared to older children (3–13
years) (p = 0.028). This supports observations from a
recent carriage study in Kathmandu, Nepal where
44.4 % (132/297) of the pneumococcal serotype positive
swabs from children aged 0–24 months contained one
or more PCV13 serotypes [32]. This finding suggests
that children in this age group are a reservoir of vac-
cine serotypes. Targeting this group for pneumococcal
conjugate vaccination would therefore prevent the spread
of vaccine serotypes within the community, thereby ensur-
ing herd immunity.
Carriage of NT strains represented <1 % of all the car-
ried population detected in Malawian children. Three
categories of NTs have been reported recently [33] based
on (i) complete deletion of the cps gene cluster (NT1),
(ii) the sole presence of novel surface protein nspA gene
(NT2) at the CPS locus or (iii) the presence of aconserved aliB-cluster (NT3) at the CPS locus. NTs are
usually associated with carriage rather than IPD [34],
which could explain why they are not included in the
current vaccine formulations. However, a recent study
reported that the highest rates of genetic recombination
occurred in NT pneumococcal strains, which suggests
their potential importance in genetic exchange events as
well as species adaptation [9]. Although children in
Malawi carried only a small proportion of NTs (<1 %),
the ability by NTs to recombine readily may be central
to the spread of antibiotic resistance, which could have a
negative impact on disease control efforts.
At 40 %, we have demonstrated that the rate of mul-
tiple carriage among Malawian children is as high as has
been reported elsewhere [4, 35]. Multiple carriage is
thought to promote the horizontal gene transfer of anti-
biotic resistance and virulence genes [8, 36–38], which
may contribute to the pathogen adaptation and increased
risk of disease in the host. A recent report suggests that
multiple carriage may promote co-infection with two or
more pneumococcal serotypes [39]. It is therefore import-
ant to understand the dynamics of multiple carriage in a
given setting in order to control pneumococcal spread and
disease.
We did not find any statistically significant difference
in the prevalence of multiple carriage between HIV
negative and HIV positive children, which is similar to
our recent report in adults [14]. To date, the effect of
HIV infection on pneumococcal carriage is currently not
fully understood; hence further studies on much larger
datasets need to be conducted to address such questions.
Although pneumococcal carriage rates have been shown
to decrease with age [40], this study could not establish
the association between age and the prevalence of mul-
tiple carriage in children and further studies are there-
fore recommended.
The polysaccharide capsule is essential for pneumo-
coccal survival and transmission within the host by
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is also a target for current conjugate vaccine formula-
tions. One of the key mechanisms by which S. pneumo-
niae survives the host immune response and the effect
of vaccination is to alter its CPS locus, through muta-
tions and genetic recombination. We detected naturally
occurring CPS locus variants in vaccine-associated sero-
types 6B, 19A and 20. Although multiple carriage is
reported to promote genetic recombination through
horizontal gene transfer [42], it is not clear whether this
played a role in altering the CPS genes of vaccine sero-
types reported here.
Serotype 6B causes 10 % of IPD in young children glo-
bally and ranks second after serotype 14 [24]. In Malawi,
serotype 6B is the second most isolated strain from inva-
sive disease in children after serotype 1 [25]. In our data
set, serotype 6B variants were genetically distinct from
wildtype 6B serotypes. They demonstrated a significantly
high SNPs density (Fig. 4a) and genetic recombination
events (Fig. 4b), suggesting carriage of a different lineage
of serotype 6B in Malawi. The 6B variants also had novel
sequence types, and contained an insertion of the licD-
family phosphotransferase gene (Fig. 5). To ascertain the
potential behaviour of the 6B variants under vaccine pres-
sure as the national programme expands, further work in
mouse models is recommended.
The cps locus variant of serotype 19A showed an in-
version in the rmlD gene (Fig. 6). Although inversions
do not change the genetic composition of the sequence,
recent findings suggest gene inversions may actually
lower the expression level of the affected gene, resulting
in abnormalities at phenotypic level [43]. In our setting,
the rmlD gene inversion in the 19A variant may impair
the functionality of the whole rml gene cluster necessary
for rhamnose biosynthesis, a component of the polysac-
charide capsule. This could lead to the production of an
altered 19A capsule, which may not be recognised by the
vaccine.
A structural difference of the polysaccharide capsule
within serogroup 20 has previously been reported [44].
This structural difference was due to a truncation and
loss of function of the whaF gene [44]. The truncation
in the whaF gene correlated with the loss of an αGlc
residue in the capsular polysaccharide repeat unit of
serotype 20A [44]. The Malawian serotype 20 variants
contained a 716 bp deletion within the whaF gene
(Fig. 7). This deletion would render the whaF gene
non-functional, leading to a loss of an αGlc residue in
the capsular polysaccharide repeat unit of the variant.
It is therefore likely that the serotype 20 variants cir-
culating in Malawi belong to subtype 20A. However, it
is unclear how this deletion affects the ability of the 20
variant to colonise and cause invasive disease, al-
though harbouring an intact allele of the whaF genehas been associated with invasive strain strains of sub-
type 20B [44].
This study had some limitations, which made it impos-
sible to draw some conclusions from the analysis. Be-
cause of the limited sample size, we were not able to
characterise serotype-specific associations in multiple
carriage. To address such limitations, a follow up study
with additional samples would be recommended in this
population. The microarray technique employed has
limited ability to discriminate closely related serotypes,
which are detected as a group, however this limitation is
common to all known phenotypic and genotypic sero-
typing methods [45]. In addition, microarray cannot dif-
ferentiate NTs from the Mitis-group Streptococci on
pneumococcal positive samples [32], which may lead to
an inaccurate estimation of NTs in carriage.
Conclusions
The aim of the study was to characterise the circulating
carriage profile and distribution of pneumococcal sero-
types in Malawian children, by microarray.
The data clearly showed that Malawian children are
exposed to a broad range of serotypes. We have shown
that a large proportion of vaccine serotypes were detect-
able in younger children who represent the primary tar-
get group for PCV13. In particular, the high carriage rate
of non-vaccine serotypes has the potential to drive sero-
type replacement with increasing and widespread usage
of PCV13, in Malawi, based on the evidence of increas-
ing IPD cases caused by non-vaccine serotypes 15A and
23B in Germany post PCV13 [31]. Multiple carriage is
also common, and has the potential to generate further
serotype (CPS) variants through horizontal gene transfer.
The variants in this study also reflect naturally occurring
variations. Selective pressure from vaccination may ex-
acerbate CPS locus genetic variations and could ultim-
ately promote vaccine escape.
To our knowledge, this is the first study to report such
pneumococcal serotype diversity and rates of multiple
carriage in Malawian children. The data generated pro-
vide a good scientific baseline for measuring the impact
of vaccine introduction in Malawi, and also for predict-
ing which serotypes may emerge post vaccination. Such
information will be invaluable for vaccine policy.
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